RYR2 and catecholaminergic polymorphic ventricular tachycardia: Genetic mutations have been identified in RyR2 and its multiple accessory proteins that cause a genetic arrhythmia syndrome called catecholaminergic polymorphic ventricular tachycardia (CPVT) [2,4].